These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2905813)

  • 1. Neurochemical studies on the mechanism of action of pyritinol.
    Greiner HE; Haase AF; Seyfried CA
    Pharmacopsychiatry; 1988 Aug; 21 Suppl 1():26-32. PubMed ID: 2905813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of some metabolites of pyritinol (Encephabol) on ACH release from brain slices.
    Martin KJ; Tucker L; Widdowson L
    Pharmacopsychiatry; 1988 Aug; 21 Suppl 1():33-6. PubMed ID: 3217429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nootropic drugs on brain cholinergic and dopaminergic transmission.
    Pavlík A; Benesová O; Dlohozková N
    Act Nerv Super (Praha); 1987 Mar; 29(1):62-5. PubMed ID: 3035858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyritinol inhibition of the GABA and benzodiazepine receptor.
    Turský T
    Physiol Bohemoslov; 1988; 37(5):417-26. PubMed ID: 2851848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of benzoyltropine and tropacocaine on several cholinergic processes in the rat brain.
    Meyer EM; Potter LT; De Vane CL; Irwin I; MacKay SL; Miller R; Ruttenber AJ
    J Pharmacol Exp Ther; 1990 Aug; 254(2):584-90. PubMed ID: 1974643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in acetylcholine concentrations in the brain of 'old' rats following treatment with pyrithioxin (Encephabol).
    Martin KJ; Vyas S
    Br J Pharmacol; 1987 Mar; 90(3):561-5. PubMed ID: 3567461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyritinol reduces nociception and oxidative stress in diabetic rats.
    Jiménez-Andrade GY; Reyes-García G; Sereno G; Ceballos-Reyes G; Vidal-Cantú GC; Granados-Soto V
    Eur J Pharmacol; 2008 Aug; 590(1-3):170-6. PubMed ID: 18593582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH; Günzler WA; Flohé L
    Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choline uptake, acetylcholine synthesis and release, and halothane effects in synaptosomes.
    Johnson GV; Hartzell CR
    Anesth Analg; 1985 Apr; 64(4):395-9. PubMed ID: 3842799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pyritinol on the dopaminergic system and behavioural outcome in an animal model of mild chronic postnatal hypoxia.
    Lun A; Gruetzmann H; Wustmann C; Szuesz L; Dominick B; Horvath G; Fischer HD; Nagy I; Gross J
    Biomed Biochim Acta; 1989; 48(2-3):S237-42. PubMed ID: 2730616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroconvulsive shock and neurotransmitter receptors: implications for mechanism of action and adverse effects of electroconvulsive therapy.
    Lerer B
    Biol Psychiatry; 1984 Mar; 19(3):361-83. PubMed ID: 6144329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the neurotoxic effects of manganese during development and aging: some observations on brain regional neurotransmitter and non-neurotransmitter metabolism in a developmental rat model of chronic manganese encephalopathy.
    Lai JC; Leung TK; Lim L
    Neurotoxicology; 1984; 5(1):37-47. PubMed ID: 6144083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyritinol hydrochloride and cognitive functions: influence on children in slow learner classes.
    Wälti U; Kuenzler M; Schild J; Vassella F; Pavlincova E; Bircher J; Herschkowitz N
    Pediatr Res; 1975 Sep; 9(9):717-21. PubMed ID: 1105370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A placebo-controlled study of pyritinol ('Encephabol') in dementia.
    Cooper AJ; Magnus RV
    Pharmatherapeutica; 1980; 2(5):317-22. PubMed ID: 7001490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related changes in rat brain monoamines release: peculiarity of dopamine release.
    Cerrito F; Aloisi G; Arminio P
    J Neurosci Res; 1993 Feb; 34(3):364-70. PubMed ID: 8095990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms.
    Giorgi M; D'Angelo V; Esposito Z; Nuccetelli V; Sorge R; Martorana A; Stefani A; Bernardi G; Sancesario G
    Eur J Neurosci; 2008 Sep; 28(5):941-50. PubMed ID: 18717735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of neuroleptics on acetylcholine concentration and choline uptake in striatum: Implications for regulation of acetylcholine metabolism.
    Sherman KA; Hanin I; Zigmond MJ
    J Pharmacol Exp Ther; 1978 Sep; 206(3):677-86. PubMed ID: 29960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the effects of pyritinol on functional deficits of patients with organic mental disorders.
    Herrmann WM; Kern U; Röhmel J
    Pharmacopsychiatry; 1986 Sep; 19(5):378-85. PubMed ID: 3534901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyritinol and the enzymes of gamma-aminobutyric acid (GABA) synthesis and degradation.
    Turský T
    Physiol Bohemoslov; 1988; 37(2):135-43. PubMed ID: 2975003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acute and chronic ethanol administration and withdrawal on adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate levels in the rat brain.
    Volicer L; Hurter BP
    J Pharmacol Exp Ther; 1977 Feb; 200(2):298-305. PubMed ID: 190377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.